Skip to content

Study on the effective prescriptions for the treatment of liver injury and their anti-inflammatory and hepatoprotective mechanisms by famous old Chinese medicine practitioners

Study on the effective prescriptions for the treatment of liver injury and their anti-inflammatory and hepatoprotective mechanisms by famous old Chinese medicine practitioners

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2022000097
Enrollment
Unknown
Registered
2022-06-27
Start date
2022-09-17
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic liver injury

Interventions

observation group:no

Sponsors

Guang'anmen Hospital, Chinese Academy of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: ? Diseases related to abnormal liver function that have been differentiated and treated by famous Chinese medicine practitioners, mainly including: viral hepatitis, alcoholic liver disease, non-alcoholic steatohepatitis, autoimmune hepatitis, liver cirrhosis, drug-induced liver injury, etc.; ? Complete medical record information, including: general information of patients, symptoms and signs, information on four diagnoses, diagnosis of traditional Chinese and Western medicine, syndromes, principles and methods of treatment, name and composition of prescriptions, auxiliary examinations, etc.; ? Mainly using traditional Chinese medicine treatment, including pure traditional Chinese medicine treatment, or using traditional Chinese medicine alone for more than 80% of the time in the treatment cycle; ? There is information on follow-up visits, at least 2 visits, and liver function assessment before and after treatment, with written records or auxiliary examinations that clearly prove the curative effect.

Exclusion criteria

Exclusion criteria: ? The patient's medical record information and data are incomplete, which affects the assessment and data analysis; ? Combined with acute and chronic serious diseases of important organs (such as heart, brain, lung, liver, kidney).

Design outcomes

Primary

MeasureTime frame
prescription;

Countries

China

Contacts

Public ContactYuning Bai

Guang'anmen Hospital, Chinese Academy of Traditional Chinese Medicine

byn-1973@163.com13366266838

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026